Sera Prognostics
Angela Fox has a diverse work experience spanning over two decades. Angela currently holds the position of Vice President of Clinical Operations at Sera Prognostics, a role they began in January 2022. Prior to this, they served as the Associate Vice President of Clinical Operations at Sera Prognostics, Inc. from February 2017 to January 2022, and as the Director of Clinical Operations from November 2011 to February 2017. Angela also worked at Pfizer, Inc. as an Associate Director of Regional Rare Disease Specialist from April 2010 to November 2011, where they provided support in the field of rare genetic disorders. Angela'searly career includes roles at the University of Washington as a Certified Genetic Counselor from October 2002 to March 2010, and at the National Cancer Institute, National Institutes of Health as a Technical Cancer Research Training Award (CRTA) recipient from October 1997 to July 1999.
Angela Fox completed their Bachelor of Science degree in Molecular Biology from Salem University, where they studied from 1993 to 1996. Following their undergraduate studies, they pursued further education at the University of Colorado Anschutz Medical Campus from 1999 to 2001, earning a Master's degree in Genetics/ Genetic Counseling.
This person is not in any offices
Sera Prognostics
Sera Prognostics is a leading proteomic and bioinformatics company dedicated to improving the lives of women and babies through precision biomarker-based tests designed to enhance pregnancy care. Sera’s vision is to deliver pivotal information in early pregnancy to physicians, to help them to improve the health of their patients and reduce costs of healthcare delivery.